Corticoterapia associada à COVID-19 : uma aliada ou um fator de risco para o estabelecimento de co-infecções fúngicas?
Visualizar/abrir
Data
2021Orientador
Co-orientador
Nível acadêmico
Graduação
Assunto
Abstract
Infections such as aspergillosis and mucormycosis have been frequent in COVID-19 patients, contributing to the increased mortality rate in these patients. Corticosteroid therapy to combat SARS-CoV-2 inflammation seems to be a risk fator for the development of secondary fungal co-infections, along with the presence of comorbities in this group of patients. Thus, this study carried out a literature review addressing the main influences related to corticosteroid therapy and predisposition to comor ...
Infections such as aspergillosis and mucormycosis have been frequent in COVID-19 patients, contributing to the increased mortality rate in these patients. Corticosteroid therapy to combat SARS-CoV-2 inflammation seems to be a risk fator for the development of secondary fungal co-infections, along with the presence of comorbities in this group of patients. Thus, this study carried out a literature review addressing the main influences related to corticosteroid therapy and predisposition to comorbidities, such as diabetes mellitus, arterial hypertension, cardiovascular diseases and chronic obstructive pulmonary disease (COPD) in the development of fungal co-infections in COVID-19 patients. As a result, the use of corticosteroid therapy to combat inflammation by SARS-CoV-2 has been associated with the establishment of fungal co-infections, especially mucormycosis and aspergillosis. According to published studies, mucormycosis, besides being more frequent, was the main fungal co-infection related to corticosteroid therapy, causing a higher number of deaths in COVID-19 patients. Furthermore, the presence of diabetes mellitus was the most prevalent comorbidity in the cases analyzed, mainly for the establishment of mucormycosis. The use of dexamethasone demonstrated a greater association with the emergence of mucormycosis cases that led to death. Meanwhile, aspergillosis was closely related to recovery cases. Thus, risk factors such as diabetes mellitus, combined with the use of corticosteroids such as dexamethasone seem to present a greater correlation to the establishment of mucormycosis. According to evaluated studies, patients exposed to these circumstances had a higher lethality when compared to others. Finally, the use of corticotherapy in COVID-19 patients should be analyzed individually, considering mainly the patient's medical history and the risk/benefit ratio of using these medications. ...
Instituição
Universidade Federal do Rio Grande do Sul. Faculdade de Farmácia. Curso de Farmácia.
Coleções
-
TCC Farmácia (787)
Este item está licenciado na Creative Commons License


